Proposed therapeutic algorithm for patients with ECD. Asterisk (*) indicates that molecular testing of non-BRAF mutations, performed using next-generation sequencing, is recommended for BRAF wild-type cases, either immediately when found to be BRAF wild-type or if there is disease progression on treatment.